Posted in M&A / Deals MSD-backed Ray locks in $125m to back eye drug pipeline April 22, 2026 Pharmaceutical Technology Ray’s MSD and Novo Holdings-backed Series B will shed light on the potential of the company’s vision restoration gene therapy pipeline. M&A / DealsOphthalmologyRead full story